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HIV drug resistance (HIVDR) has emerged as a major clinical and public health 
challenge in many resource poor countries especially in Africa. HIVDR testing has 
become increasingly important and is of significant value in the management of HIV. 
The use of low cost technologies and procedures in testing HIVDR is being 
recommended. HIVDR computer interpretation algorithms make use of artificial 
intelligence and other computer technologies to predict HIVDR, and are recommended 
for use in resource poor countries. However, there is little known about the knowledge, 
attitude and perception of HIVDR computer algorithms by doctors in developing 
countries who are supposed to use computer algorithms.  
 
This study aimed to determine the knowledge, attitude and perception regarding 
computer interpretation algorithms of the 4th and 5th year medical students at Nelson R. 
Mandela School of Medicine, University of KwaZulu Natal in South Africa. Primary 
data collection was done using a questionnaire administered to a convenience sample 
of 216 4th and 5th year medical students. The study revealed that 90% of the respondents 
were aware of HIV drug resistance testing in South Africa but only 4% had knowledge 
of the computer interpretation algorithms. The study revealed that although the UKZN 
medical students are not aware of computer interpretation algorithms, majority are 
willing to use them in the future.   
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The vast majority of HIV infections occur in resource limited settings (RLS) (Struck et 
al., 2012). Access to antiretroviral treatment (ART) programs in these settings have 
been widely improved following WHO recommendations and international funding 
efforts (Struck et al., 2012). South Africa has the largest population infected with human 
immunodeficiency virus (HIV) which causes acquired immunodeficiency syndrome 
(AIDS) (Manasa et al., 2013).  All the countries in the world are intensifying measures 
to fight HIV, in order to reduce its associated morbidity and mortality (Manasa et al., 
2013). 
 
 There is currently no cure for HIV/AIDS but it can be managed by antiretroviral (ARV) 
therapy. This has changed the HIV trend significantly (Giddy et al., 2013). ARV drugs 
disrupt the HIV enzyme’s ability for genetic copying, or for making virus that can infect 
other cells (Tang et al., 2012). The ARV’s are usually being managed in the form of 
highly-active antiretroviral therapy (HAART). This is a combination of drugs that 
improves therapy and suppresses the viral load (Eberle and Guertler, 2012).  
 
HAART can fail as a result of toxicity, transmitted drug resistance, poor drug 
adherence, or poor suppression of viral copying resulting in the emergence of HIV drug 
resistance (HIVDR) (Wallis et al., 2010). HIVDR refers to, ‘a reduction in the ability 
of a drug or combination of drugs to block duplication or replication of HIV’ (Tang et 
al., 2012). 
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The common factors that leads to antiretroviral drug resistance include high replication 
rates of the virus, selective pressure caused by the ARV drugs and initial infection by 
resistant strains of HIV (Singh and Mars, 2012). Therefore HIVDR is inevitable in 
treatment of HIV infected patients. 
 
The use of ARV’s leads to the emergence of resistant viruses which in most occurrences 
causes treatment failure (Bessong and Nwobegahay, 2013). The occurrence of HIVDR 
may limit the benefits of ART (Marconi et al., 2008). Continued spread of HIVDR 
could jeopardize efforts to curtail the epidemic in the developing world. Hence 
surveillance of HIVDR is justified (Di Giambenedetto et al., 2011).  
 
1.2 Background of Study  
 
The existence of HIVDR complicates HIV management (Kozal, 2009). As ART is 
scaled up in resource limited countries, the occurrence and transmission of HIVDR 
remains an international priority. HIVDR has to be treated with high priority as it 
endangers the effort in curbing HIV (Kozal, 2009). Wherever there are HAART 
programs in place, there is the possibility of HIVDR existence due to existence of 
HIVDR in circulation and thus endangering the success of HIV treatment (Struck et al., 
2012). Thus ARV drug resistance remain a potential threat to the control of HIV 
(Manasa et al., 2013). 
 
Efforts to provide access to ART for infected persons in resource limited countries have 
been enhanced over the past several years (Marconi et al., 2008). South Africa is said 
to have one of the largest ARV programs in the world, and thus high chances of the 
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existence of HIVDR (Castillo et al., 2011). It is therefore of paramount importance that 
HIVDR testing in South Africa be given high priority in order for the HIV treatment 
programs to be effective. The current expansion of ART in the developing world 
without routine virological monitoring still raises concerns on the outcome of the 
strategy in terms of virological success and drug resistance burden (Aghokeng et al., 
2013). 
 
1.3 Aim of the study  
 
The aim of the study was to determine the knowledge, attitude and perception (KAP) 
of fourth and fifth year medical students of Nelson R. Mandela School of Medicine 
(NRMSM) on HIV drug resistance testing in South Africa using computer 
interpretation algorithms.  
 
1.4 Research questions  
 
In order to address the aim of the study, this study attempted to answer the following 
research questions, 
1. What is the current scientific literature on HIVDR, HIVDR testing using 
computer based interpretation algorithms, particularly around KAP of medical 
students? 
2. What is the knowledge of a sample of fourth and fifth year students at NRMSM, 
on HIV drug resistance computer based interpretation algorithms? 
3. What is the attitude of a sample of fourth and fifth year students at NRMSM 
towards HIV drug resistance interpretation algorithms? 
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4. What is the perception of a sample of fourth and fifth year students at NRMSM 
towards the use of HIV drug resistance computer based interpretation 
algorithms in clinical practice? 
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A vast amount of literature related to HIV has been published as the research 
community strives to understand and find solutions to one of the worst epidemics 
affecting the world (Fernandez-Gerlinger et al., 2013; WHO, 2012).   One of the focus 
areas of HIV research is the prevalence and occurrence of HIVDR. Although a 
significant number of papers have been published concerning HIVDR (Tang et.al. 
2012; Fernandez-Gerlinger et al., 2013; WHO, 2012), there is still more work required 
to understand the issues and challenges around HIVDR.  
 
One major aspect is to increase knowledge on HIVDR especially amongst health 
practitioners in order to increase their capacity to deal with HIVDR. It is therefore 
imperative to ascertain the current state of knowledge on HIVDR. As a contribution to 
this endeavor this literature review has focused on reviewing and summarizing research 
on HIV, HIVDR, knowledge, attitude and perception of South African medical students 
on HIVDR testing with a particular focus on the use of computer interpretation 
algorithms.  
 
HIVDR testing is becoming an essential tool in managing HIV, thus, it is important to 
assess the knowledge, attitude and perception of medical students on HIVDR testing in 
order to identify education gaps, training needs with a view to informing the relevant 
stakeholders and issues that will aid change management. The gaps in knowledge lead 
to disparate attitudes and perceptions amongst clinicians leading to unevenness in HIV 
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treatment across the country. The ubiquitous appearance of drug resistance complicates 
the global spread of HIV disease, the range of resistance continues to multiply, and thus 
resistance testing has become increasingly important and very significant in the 




A comprehensive literature review was carried on using the ‘deep web’ search targeting 
published articles using the UKZN library electronic academic resources. Search terms 
shown in the table below were used to electronically search using EBSCO Host, 
Science direct and Google scholar.  The search was narrowed down by using the 
Boolean operators ‘AND’, ‘OR’, ‘NOT’. Advanced search was also used to narrow 
down the search so that relevant papers were retrieved. KAP studies were narrowed 
down to Africa and South Africa, to find out how much literature has been published 
in these areas.  
 
The inclusion criteria was all the articles published in the field of study since the 2008 
to date. No articles prior to 2008 were used in the study. The search strategy included 
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Table 1: Search terms, articles retrieved and relevant articles used in the study  
Search terms  Articles Retrieved Relevant Articles 
“HIV” and “HIV treatment” 6681 40 (used) 
 “HIV Drug Resistance” 639 21 
“HIV Drug Resistance” and “HIV Drug 
Resistance testing”  
26 9 
“HIV Drug Resistance testing methods” 
and “HIV Drug Resistance testing in 
South Africa” 
15 10 
“Genotyping” and “Phenotyping” 160 10 
“Genotyping: rule based” and “machine 
learning algorithms” 
30 10 
“KAP methods” and “KAP of medical 
students” 
23 5 
“KAP studies” 41 5 
Total  7589 110 





The Human immunodeficiency virus (HIV) is the cause of acquired immunodeficiency 
syndrome (AIDS) (Ammaranond and Sanguansittianan, 2012). It is one of the most 
infectious diseases to plague the global human population (Nyabadza et al., 2011). 
About 33 million people are infected with the human immunodeficiency virus (HIV) 
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worldwide (Fernandez-Gerlinger et al., 2013). South Africa has the largest HIV burden 
in the world, with an estimated 5.6 million people living with HIV (Manasa et al., 
2013). The dual epidemics of HIV and TB remain a leading health care challenge in 
South Africa (Giddy et al., 2013). 
 
2.4 HIV treatment  
 
There is still no cure for HIV but the disease can be managed and controlled by ART. 
Treatment of HIV infection consists of HAART, which has shown to be effective in 
suppressing viral replication in many patients (Quoc-Chinh et al., 2010). HAART 
comprises of a regimen of three drugs from at least two of the five commercially 
available antiretroviral drug classes (Singh and Mars, 2013). 
 
ART has converted HIV infection from an almost universally fatal illness to a 
manageable chronic disease (Conradie and Wilson, 2012). ART has significantly 
reduced associated morbidity and mortality in HIV positive patients in both developed 
and resource limited countries (Aghokeng et al., 2013). ART with fully suppressive 
HAART lowers viral load and significantly decreases the risk of transmission (Iwuji et 
al., 2013). The introduction of HAART has intensely improved the natural history and 
diagnosis of HIV infection and AIDS (Di Giambenedetto et al., 2011).  
 
HAART has been set as the standard treatment for HIV infection. It has helped to 
control HIV infection and the development of AIDS. The availability of new drug 
classes, such as integrase inhibitors, provide the option of alternative drug 
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combinations, thereby offering more treatment options (Bessong and Nwobegahay, 
2013).  
 
2.4.1 HAART in South Africa  
 
South Africa reacted slowly to the HIV epidemic and only managed to have the full 
ARV rollout in 2004. The past eight years have seen substantial scale-up of ART in 
South Africa, which has substantially reduced related population level mortality and 
increased life expectancy (Manasa et al., 2013).  The scaling up treatment was one of 
the largest in the world, with a 75% increase in treatment services.  
 
2.5 HIV drug resistance  
 
Figure 1: HIV Drug resistance  
 
HIVDR can be categorized as transmitted or acquired as shown in figure one. 
Transmitted drug resistance occurs when previously uninfected individuals are infected 
with a drug resistant virus (WHO, 2012).  Acquired HIV drug resistance occurs when 
Acquired 
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resistance mutations are acquired due to drug selective pressure in individuals receiving 
ARV therapy, suboptimal adherence, treatment interruptions, inadequate plasma 
concentrations or the use of suboptimal drugs or drug combination (WHO, 2012).   
 
HIVDR refers to, ‘a reduction in the ability of a particular drug or combination of drugs 
to block reproduction or replication of HIV’ (Tang et al., 2012). The prolonged use of 
HAART leads to drug resistance caused by the viral mutations that occur under drug 
pressure (Quoc-Chinh et al., 2010). Resistance occurs as a result of alterations called 
mutations in the HIV’s genetic structure (RNA) (Tang et al., 2012). These mutations 
lead to changes in certain proteins, most commonly enzymes that regulate the 
production of infectious virus (Tang et al., 2012). HIV mutates at a very high rate, and 
does not contain the proteins required to correct mistakes made during copying of the 
genetic material (Tang et al., 2012).  Interruption of HAART or failure to take ARV 
drugs on schedule and in the prescribed dosage can encourage the development of drug 
resistant HIV strains (Kolupajeva et al., 2008). 
 
Access to ART for treatment of HIV infections is increasing throughout the developing 
world (Castillo et al., 2011). Eight years after the introduction of ARV’s in public health 
facilities in South Africa, the development of resistance and treatment failure has begun 
to appear (Bessong and Nwobegahay, 2013). HIVDR is emerging and is weakening 
available treatment options (Castillo et al., 2011). Individuals with ARV drug resistance 
have a relatively higher risk of virologic failure as they start ART with a lower genetic 
barrier to resistance (Nwobegahay et al., 2011). 
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2.5.1 Transmitted drug resistance  
 
HIV drug resistance can be categorized as, transmitted resistance, which occurs when 
previously uninfected individuals are infected with a drug resistant virus (WHO, 2012). 
A newly infected patient can carry a drug resistant virus even though not on ARV 
treatment. Transmitted HIVDR is therefore a major concern as it increases the risk of 
virologic failure, this can be relevant where there are limited treatment options. The 
transmitted HIVDR infected patient starts therapy with a lower genetic barrier to 
resistance, higher risk of virologic failure and a higher risk of developing resistance to 
drugs in the regimen that they were originally susceptible to (Bonney et al., 2013). 
Surveillance of HIV transmitted drug resistance in recently infected individuals is key 
to the WHO strategy (Castillo et al., 2011). The prevalence of transmitted drug 
resistance in middle to low income countries is estimated to be around 7% (Pennings, 
2013).  
 
2.5.2 Acquired drug resistance  
 
Acquired resistance, occurs when resistance mutations emerge because of drug 
selective pressure in individuals receiving ARV’s (WHO, 2012). Acquired HIV drug 
resistance occurs when resistant mutations are acquired due to drug selective pressure 
in individuals receiving ARV therapy, suboptimal adherence, treatment interruptions, 
inadequate plasma concentrations or the use of suboptimal drugs or drug combinations 
(WHO, 2012).   
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Both acquired and transmitted HIV drug resistance are public health concerns 
(Kolupajeva et al., 2008). Surveillance of both transmitted and acquired resistance can 
supply information to support public health bodies in designing preventive action to 
minimize the development and transmission of drug-resistant viruses (Kolupajeva et 
al., 2008). 
 
2.5.2.1 Mutation rate  
 
HIV replicates at a high rate in untreated patients. The rate at which mutations accrue 
in the HIV genome has great implications for the management of individuals with HIV 
because it impacts the effectiveness and pharmacoeconomics of HAART (Wensing et 
al., 2010). Resistance to HAART and adherence to HAART determine the level of 
HAART effectiveness. Although greater HAART effectiveness will suppress viral load 
more completely, it will also increase selection pressures for particular mutations that 
could produce resistance to one or more drugs in the round (Braithwaite et al., 2007). 
 
2.5.2.2 Selective pressure  
 
Drug resistant HIV progresses in response to selective pressure applied by the ARV 
drugs in the patient's system (Wensing et al., 2010).  Resistant strains may develop 
through selective pressure during ART. Specific resistance mutations develop in 
response to the pressure exerted by specific drugs (Fehr et al., 2008). The presence of 
viral resistance suggests that a particular drug, and drugs with similar resistance 
patterns, or cross-resistance, is unlikely to be successful in suppressing viral replication 
(Ammaranond and Sanguansittianan, 2012). 




Greater HAART effectiveness reduces the rate of viral replication and therefore 
decreases opportunities to produce mutations overall, however, the mutations that do 
occur are produced in an environment of high selection pressure because of the 
effectiveness of the therapy against wild type virus. As resistance accrues, the viral 
replication rate increases, and this in turn increases the probability that subsequent 
mutations will develop. The effectiveness of HAART influences changes in the viral 
load and cd4 count and also feeds back to influence the viral replication rate and 
selection pressures (Shi et. at., 2010). 
 
2.5.2.3 Low genetic barrier  
 
The genetic barrier to resistance development is usually defined by the number of 
resistance associated mutations necessary to confer virological failure. However, other 
factors also have to be taken into consideration. If viral copying is incompletely 
suppressed, the likelihood of selecting a new mutation is high. If a single mutation 
occurs, sufficient to restore growth, the selective pressure experienced by the virus will 
be lost and selection of additional mutations will not occur (Wensing et al., 2010).  
 
2.5.2.4 Drug adherence 
 
It is widely accepted that for HIV positive persons on highly active antiretroviral 
therapy (HAART), high levels of adherence to treatment regimens are essential for 
promoting viral suppression and preventing drug resistance. 
 
   
14 
 
HIV drug resistance can emerge among people on treatment even when appropriate 
ARV therapy is provided and high levels of adherence are achieved. Optimal adherence 
to HAART is essential to HIV infected individuals accessing treatment (Musiime et al., 
2011). Poor adherence to HAART can lead to HIV disease progression, evolution of 
drug resistance and subsequent immunological, evolution and clinical failure (Musiime 
et al., 2011).  
 
Because ART can fail as a result of toxicity, pre-treatment HIV drug resistance, 
insufficient patient adherence or incomplete suppression of viral replication leading to 
the emergence of drug-resistant viruses, adequate clinical and biological management 
can significantly improve treatment outcome and can prevent rapid failure (Aghokeng 
et al., 2013). 
 
2.6 HIV drug resistance testing 
 
HIVDR testing is used to guide subsequent treatment for patients whose ART is failing 
and for those whose viral load is not completely suppressed after starting therapy. It is 
recommended to patients with multiple drug failure, newly infected individuals and for 
pregnant women who are not on ART and for those who are on ART but have a 
detectable HIV viral load as transmission of resistant HIV mutants to therapy naïve 
individuals are a rising concern (Fehr et al., 2008). 
 
It can also be used to select an initial regimen that is likely to be effective for patients 
who have never been treated, and it is recommended for all patients with HIV infection, 
both acute and chronic upon entry into care, whether or not ART is to be initiated 
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(Manasa et al., 2013). In addition, resistance testing is recommended for pregnant 
women. 
 
The development of drug resistance is one of the major challenges challenging 
management of effective therapy against HIV (Ammaranond and Sanguansittianan, 
2012). South Africa follows the public health approach to ART delivery with 
standardized drug regimens and simplified decision making, with the inclusion of 
routine viral load monitoring for the detection of treatment failure (Manasa et al., 2013).   
 
Countries should step up monitoring of HIVDR and take steps to guard against 
inconsistent taking of medication that fuels the problem. WHO has recommended 
countries to begin surveillance in areas where ART has been available for years because 
even where effective ART is available, drug resistance remains a crucial issue (WHO, 
2012). 
 
Viral load monitoring should enable early identification of treatment failure and this 
has been shown to improve survival and health of the HIV infected people (Manasa et 
al., 2013). There is need for nationwide drug resistance surveillance to be in place to 
meet the emerging need and be able to detect the resistance pattern. This will assist in 
the type of drugs to include on the ARV programs and also to eliminate the 
compromised drugs in the treatment plan and be able to obtain the drugs that will impact 
the treatment program.  
 
With HIV drug resistance testing in place, the relevant departments will be able to plan 
ahead and be able to yield good results in HIV management program as a whole and 
   
16 
 
this will benefit the country at large.  HIV drug resistance testing has been shown to 
improve ARV treatment outcomes and is broadly recommended as standard of care in 
current treatment guidelines (Pattery et al., 2012). Drug resistance can be directly 




HIV drug resistance testing may be performed by direct measurement of virus 
susceptibility to drugs, the laboratory testing (Guertler et al., 2012). Phenotype testing 
works by splicing the HIV reverse transcriptase and HIV protease genes from a patient's 
virus into a standardized laboratory strain, which is then grown in the presence of 
escalating concentrations of ARV drugs (Fehr et al., 2008). A phenotype testing takes 
2-3 weeks to complete. 
 
Phenotype resistance testing assesses viral expression (Fehr et al., 2008) and virus drug 
susceptibility. A special form of it, the replicative phenotypic resistance test utilizes 
several replication cycles of a recombinant infectious virus to follow viral propagation 
in the presence of antiretroviral drugs (Fehr et al., 2008). 
  
However phenotyping, is performed in laboratories. The laboratory testing, requires 
sophisticated laboratories and can be very expensive to run and maintain, time 
consuming, easily susceptible to error and each test detects resistance pertaining to a 
single drug. The limitations of phenotypic include, longer turnaround time, expense, 
and biological cut off for clinical resistance has not been developed for all antiretroviral 
agents (Pattery et al., 2012).  




2.6.2 Genotype testing 
 
Figure 2: Genotype testing 
 
Interpreting the results of HIV genotypic drug-resistance tests is one of the most 
difficult challenges facing clinicians who care for HIV infected patients. The results 
can be human or computer interpreted. The currently developed computational 
algorithms to assist physicians in interpreting the results seems to be more capable in 
assisting physicians in selecting the most suitable treatment regimen. There are two 
methods available to computationally interpret the HIV drug resistance results, rule-
based approach and machine learning (Quoc-Chinh et al., 2010) (figure 2). 
 
Rule based algorithms were deduced by experts in the field, by making use of literature 
data on correlations between geno and phenotype as well as correlations with treatment 
history and clinical response (Soo-Yon, et. al., 2009).  On the other hand, bioinformatics 




Rule based algorithms Machine learning 
algorithms 
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mathematical models for prediction of phenotypic drug resistance and therapy response 
from genotype.  
 
Other examples of bioinformatics approaches based on analyses of large databases are 
the artificial neural networks that can predict resistance from complex mutation 
patterns and virological response from treatment and resistance history or the 
Bayesian networks that can predict individual in vivo evolution towards resistance 
under drug selective pressure (Soo-Yon, et. al., 2009).  
 
A genotypic test takes a week to perform and the results are reported as a list of detected 
mutations (Pattery et al., 2012). The genotypic assay is the preferred assay at the 
moment for practical reasons. Genotypic assays are less expensive, have a shorter 
turnaround time and are superior at detecting evolving resistance (Tang et al., 2012).  
Bioinformatics algorithms have been developed for the interpretation of resistance from 
sequence submission, which supports clinical decision making (López-Lopes et al., 
2013).  
 
Genotype testing is faster and cheaper than phenotype testing, and it can detect 
emerging resistance, that is, virus with a mixture of strains of which some may be 
sensitive and some may be resistant to a given drug, as long as they are present in 
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2.6.2.1 Rule based algorithms  
 
HIV-GRADE is an algorithm that presents the option of seeing the rules and results of 
other drug resistance algorithms for a given sequence simultaneously (Obermeier et al., 
2012). These systems employ rule based algorithms with rules derived from literature 
or expert opinion to interpret the results. The rules for HIV-GRADE are taken from the 
literature, clinical follow-up data and from a bioinformatics-driven interpretation 
system (geno2pheno). 
 
Today several unique rule based algorithms are very well established, these include 
systems such as Stanford HIVDB http://hivdb.stanford.edu, ANRS (National Agency 
for AIDS Research, France), and RegaDB http://www.rega. kuleuven.be/cev/regadb. 
 
HIV drug resistance data are updated with resistance data manually gleaned from 
scientific publications by experts in this field (Quoc-Chinh et al., 2010).  Some of these 
algorithms are freely available, namely the HIV Stanford Resistance Database (HIVdb) 
and the geno2Pheno (G2P). These are two of the algorithms most commonly used by 
researchers and physician worldwide (López-Lopes et al., 2013). 
 
2.6.2.2 Machine learning algorithms  
 
Machine learning algorithms learn from a training data set and then test their 
performance using a test data set (Quoc-Chinh et al., 2010). They contain mathematical 
models developed by a computer program that analyses data linking genotype to 
phenotype or clinical outcome. This process is necessary to prevent these algorithms 
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from learning concepts that are too specific to the training set and thus not applicable 
to other sets of data.   
 
Several interpretation algorithms of the interpretation of the genotyping of HIV viral 
strain have been developed to better understand and characterize resistance in clinical 
samples (López-Lopes et al., 2013). They are cheaper, faster, less technically 
challenging and can yield multi-drug resistant profiles, and thus preferred and 
recommended for use in the developing countries where resources are still limited 
(Aitken et al., 2012). 
 
Alongside patient’s treatment history, the genotypic algorithms may be employed to 
predict resistance to ARV drugs and help physicians with a fast and reliable method of 
determining the most adequate HAART option for each individualised salvage regimen 
(López-Lopes et al., 2013).  
 
However correct interpretation of the mutational patterns is not straightforward, and 
consensus is still lacking on this matter. It remains a challenge to keep those 
interpretation systems up to date and improve their usefulness for clinicians treating 
HIV-infected patients. Development of new knowledge on resistance related mutation 
is still accumulating and new classes of drugs and drugs are still being implemented in 
clinical practice (Vercauteren, et. al., 2013). Guidelines stressing regular updating and 
proper clinical evaluation of interpretation algorithms is definitely needed so that they 
can be uniform.  
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2.7 KAP of HIV drug resistance  
 
No literature on KAP of HIVDR was retrieved. This shows a gap in literature that needs 
to be filled through further studies.  
 
2.8 KAP method 
 
Knowledge, attitude, and perception (KAP) surveys are widely used to gather 
information for planning public health programs in countries (Launiala, 2009). Before 
beginning the process of creating awareness in any given community, it is first 
necessary to assess the environment in which awareness creation will take place. 
Questionnaires are the primary method that can be used to collect measureable data. A 
KAP survey uses quantitative questionnaires that provide access to quantitative and 
qualitative information (Launiala, 2009). The specific objective of this the KAP study 
was to assess the level of knowledge, attitude and perception of NRMSM medical 
students on the use of HIVDR computer interpretation. 
 
A structured questionnaire with easy to answer questions on demographic data, basic 
knowledge on information communication technology, knowledge on HIVDR and 
HIVDR testing methods was used. Understanding the levels of knowledge, attitude and 
perception will allow for a more efficient process of awareness creation as it will allow 
the program to be tailored more appropriately to the needs of the community. 
 
 





Literature explained the existence of HIV drug resistance and the importance of HIVDR 
testing when managing HIV patients. The importance of computer technologies in 
performing HIVDR testing has been supported. No literature was found on the KAP of 
clinicians or the use of these computer technologies in South Africa and Africa at large.   
 
Despite their existence, there are gaps in the literature on KAP of South African medical 
student doctors on the use of the computer interpretation algorithms in the management 
of HIV treatment.  In order to cope with the HIV guidelines being published by World 
Health Organization (WHO), it is important for medical students to be knowledgeable 
about HIVDR testing with the use of computer interpretation algorithms, thus adhering 
to universal HIV clinical guidelines in order to maintain quality care in HIV patients in 
the country. 
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CHAPTER 3: RESEARCH PAPER 
 
Knowledge, attitude and perception of 4th and 5th year UKZN 
Medical School students towards the use of HIV Drug 






South Africa has the largest HIV burden in the world, with an estimated 5.6 million 
people living with HIV (Manasa et al., 2013). The emergence of drug resistant viral 
strains is an obstacle in the effective management of HIV infection and AIDS (Bonney 
et al., 2013). Hence HIV drug resistant testing is an international priority.  
 
3.2 Study Objectives 
 
 
The aim of this study was to provide baseline data on knowledge, attitude and 
perception of undergraduate medical students at NRMSM on the use of genotyping 
interpretation algorithms already available for use either freely or commercially for 
HIV drug resistance testing.  
 
3.3 Paper publication  
 
Rule MR9c of the University of KwaZulu Natal allows for a masters dissertation to be 
in the format of a paper for submission to a journal with additional interactive material.  
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Some of the findings of this study was presented and published at the ICT 4 Health 
2013 conference (Zhandire, T. and Singh, Y. Knowledge of 4th and 5th year UKZN 
medical school students regarding HIV drug resistant interpretation algorithms. 
ICT4Helath 2013, Cape Town, South Africa. September 2013). The presentation is 
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HIV drug resistance (HIVDR) has emerged as a major clinical and public health 
challenge in many resource poor countries, especially in Africa. HIVDR testing has 
become increasingly important and is of significant value in the management of HIV. 
The use of low cost technologies and procedures in testing HIVDR is being 
recommended. HIVDR computer interpretation algorithms make use of artificial 
intelligence and other computer technologies to predict HIVDR and are recommended 
for use in resource poor countries. However, there is little known about the knowledge, 
attitude and perception of doctors in developing countries of HIVDR computer 
algorithms. This study aimed to determine the knowledge, attitude and perception 
regarding computer interpretation algorithms of the 4th and 5th year medical students at 
Nelson R. Mandela School of Medicine, University of KwaZulu-Natal in South Africa. 
Primary data collection was by a questionnaire administered to a convenience sample 
of 216 fourth and fifth year medical students. The study revealed that 90% of the 
respondents were aware of HIV drug resistance testing in South Africa but only 4% had 
knowledge of the computer interpretation algorithms, and although the UKZN medical 
students are not aware of computer interpretation algorithms they are willing to use 











South Africa has the largest HIV burden in the world, with an estimated 5.6 million 
people living with HIV (Manasa et al., 2013). HAART comprises a regimen of three 
drugs from at least two of the five commercially available antiretroviral drug classes, 
and is used to manage HIV infection (Singh and Mars, 2013). 
 
There is an on-going rapid scale up of access to ARV therapy in countries where there 
is high prevalence incidence of HIV infection (Kozal, 2009). Access to antiretroviral 
treatment in resource-limited-settings is inevitably paralleled by the emergence of 
human immunodeficiency virus drug resistance (HIVDR) (Struck et al., 2012).  
 
When mutations or changes to the genetic structure of HIV have occurred, making the 
virus resistant to HIV medication regimen, it is referred to as HIVDR. The genetic 
changes that would have occurred allow the HIV virus to reproduce despite the presence 
of HIV medications (Nwobegahay et al., 2011). HIVDR is facilitated through high 
replication rates, selective pressure, poor drug adherence levels, and initial infection 
with a drug resistant strain of the virus (Rusine et al., 2013).  
 
HIVDR can be categorized as, transmitted resistance, which occurs when previously 
uninfected individuals are infected with a drug-resistant virus, and acquired resistance, 
which occurs when resistant mutations emerge because of drug-selective pressure in 
individuals receiving antiretroviral therapy (WHO, 2012). The prevalence of 
transmitted HIVDR is recorded highest in countries with early ART roll out and high 
ART coverage (Rusine et al., 2013). 
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HIVDR complicates standard HAART treatment, and thus testing of HIV resistance 
before initiation of any therapy may be beneficial (Nwobegahay et al., 2011). HIVDR 
testing has become a significant diagnostic tool in the management of HIV infections 
(Struck et al., 2012). Routine surveillance of transmitted and acquired HIVDR is 
crucial. Monitoring treatment effectiveness and HIVDR testing are therefore of 
increasing importance in resource-limited settings (Struck et al., 2012).  
 
There are two principal methods for assessing resistance to antiretroviral drugs which 
are genotyping and phenotyping.  
 
Phenotypic resistance assays measure the ability of a virus to grow in different 
concentrations of ARV drugs. These consist of culturing the HIV from a patient’s blood 
sample in a laboratory setting. This method is expensive, time consuming, prone to 
error, requires skilled staff, and can only measure resistance to one ARV drug at a time 
(Singh and Mars, 2013). This laboratory testing method requires sophisticated 
laboratories which can be very expensive to setup, run and maintain in countries with 
limited resources. This has limited routine monitoring of patients receiving ARV’s in 
resource limited countries.  
 
Computer generated interpretation algorithms based on genotyping have proved to be 
effective in performing these tests and are being recommended for use. There are rule 
based and machine learning algorithms. They are quicker, less technically challenging, 
and less expensive than phynotypive and can be directly interpreted for clinical 
application (Aitken et al., 2012). 
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Many of these genotypic interpretation algorithms are available freely and 
commercially for use in South Africa but their use is limited.  
 
HIVDR management should be an important public health goal in countries with 
limited resources (Rusine et al., 2013). Knowledge gaps can only be identified when 
KAP of a sampled group is identified. When the right people are equipped with the 
correct knowledge then perception and practice will increase. If medical students are 
taught about HIVDR testing using computer interpretation algorithms, they will use 
them when managing HIV patients.  It is also vital to understand the KAP of a 
population so as to draw effective intervention strategies. There is no literature on the 
knowledge, attitude and perception towards the use of these algorithms by medical 
students who on completion will be expected to use them in clinical practice. 
 
 
This will assist in noting the gaps in development towards a goal that needs to be 
achieved as a country, in this case controlling and curbing HIVDR and improving the 
lives of HIV positive patients.  
 
The aim of this study was, to provide baseline data on the knowledge, attitude and 
perception of undergraduate medical students at NRMSM on the use of genotyping 
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Materials and Methods  
 
The study population consisted of all registered 4th and 5th year students of 2013.The 
students are on a five year of academic programme. Convenience sampling was used 
and everyone in the targeted group had an equal chance of participating.  Primary data 
were collected through the use of a structured questionnaire derived from knowledge, 
attitude and perception (KAP) framework. The questionnaire was tr with students to 
and correct any ambiguity. The questionnaire was used to identify and advise the 
knowledge, attitude and perception of 4th and 5th year NRMSM medical students. 
 
 A KAP study is a representative study of a specific population to collect information 
on what is known, believed, and done in relation to a particular topic (Badran, 1995), 
in this case HIV drug resistance testing with the use of genotyping computer generated 
interpretation algorithms. It is important to understand the KAP of a community to be 
able to launch, or improve on programmes.  
 
To have maximum coverage, a combination of physical distribution of questionnaires 
and the use of a Web based survey was used.  The questionnaire was posted on the 
University Website which is accessed by all the students in the NRMSM, thus those 
willing to participate would do so.  Ethical approval for the study was obtained from 
the UKZN Humanities and Social Science Research Ethics committee, (Ethics number 
HSS/0094/013M). The permission to perform the study was also obtained from the 
UKZN Registrar’s Office.  This study was conducted with the participants' consent. 
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The questionnaire included questions probing whether the students were aware of the 
use of information communication technology (ICT) and if they support ICT use in 
their clinical practice. The knowledge section contained questions on awareness of HIV 
drug resistance in South Africa, if they had been taught about HIV drug resistance, 
whether they had ordered or seen staff ordering drug resistance tests, types of resistance 
testing used, whether results influenced changes in patient management, how 
respondents viewed the issue of drug resistance testing, and if they intend to practice 
HIV drug resistance testing with the use of genotyping interpretation algorithms in the 
future.  
 
Question responses were either dichotomous, (Yes, No) or five point Likert terms 
(unimportant, of little importance, moderately important, important, very important). 
Descriptive statistics were used to show respondents demographic characteristics. 
Categorical variables were measured as percentages. The raw data were entered into 
Microsoft Excel 2010 spread sheet and subsequently analysed. Pivot tables were used 
to study the correlation with alpha set at five percent. The Chi-squared one sample test 
was applied to test the dichotomous responses. The Chi squared test was used to 
determine if there was a difference between the respondents’ answers. This was done 
by using the goodness of fitness tests, where it was assumed that an equal distribution 










Demographic characteristics  
 
Two hundred and sixteen responses were received out of the four hundred and sixteen 
eligible participants.  The gender distribution was almost equal with 106 males and 110 
females. The majority of the respondents 82% were in the 18-25 age range, while 9.7% 
were in the 26-35 age range and 8.3% were between the ages of 36-45. In total 39% 
respondents were black, 3% were colored, 34% were Indian and 24% were white.  Of 
the 216 respondents, 54% were in 4th year.   
Information, Communication and Technology 
The respondents’ responses on the information, communication technology section 
displaying the probability values are shown in Table 1.   
Table 1: Responses to the questionnaire on the respondents’ awareness of information                      
communication and technology 
Questions Yes % 
Do you support the use of information communication technology (ICT) in 
clinical practices? 
203* 94 
Are you aware of computer based clinical decision support systems (CDSS) 
in clinical practices? 
192* 89 
Do you think the use of computer based CDSS will assist in any clinical 
decision making? 
181* 84 
Will you use computer based CDSS in the future in your practice? 181* 84 
*p value <0.001 
 
 




The respondents’ responses on the knowledge section displaying the probability values 
are shown in Table 2. 
 
Table 2: Responses to the questionnaire on the respondents’ knowledge of HIVDR 
testing 
Questions Yes % 
Are you aware of HIV drug resistance testing in South Africa? 195* 90 
Have you learnt about HIV drug resistance testing in your studies? 194* 90 
Have you covered topics on the importance of HIV drug resistance 
testing? 
173* 80 
Have you covered topics on why drug resistance testing should be done? 168* 78 
Have you covered topics on when drug resistance testing should be 
requested? 
179* 83 
Have you covered topics on who should do drug resistance testing? 175* 81 
Have you covered topics on the relevancy of HIV drug resistance in HIV 
management? 
173* 80 
Have you learnt about using computer generated artificial intelligence 
machine learning interpretation algorithms in your studies? 
9* 4 
Do you think it is important to test for HIV drug resistance when 
managing an HIV patient? 
181* 84 
Have you ever dealt with an HIV drug resistant patient? 7* 3 
 Have you ever seen the clinician managing an HIV case order 
HIV drug    
            resistance tests? 
210* 97 
 If yes, was it phenotypic methods? 205* 95 
 If yes, was it genotypic method? 11* 5 
Did they use interpretation algorithms to assist in choosing an optimal 
drug combination? 
11* 5 
Did the results cause the clinician managing the case to change the 
treatment regimens? 
108 50 
Do you think the clinical guidelines are being followed in South Africa? 164* 76 
Question  No Testing at all Very little 
testing 
 
How much resistance testing do you think is 
being done in South Africa  














The respondents’ responses to the attitude section are shown in the Table 3.   
 
 
Table 3: Attitude responses to the issue of HIVDR testing 







How important do you 
see the issue of drug 
resistance testing in 
reference to what you 
have encountered in 
clinical practice or 
your knowledge 
14 (7%) 32(15%) 0 71 (33%) 99 (46%) <0.001 
How important do you 
consider HIV drug 
resistance testing with 
the use of 
interpretation 
algorithms when 
virological failure has 
occurred? 
39 (18%) 48(22%) 19 (9%) 25(12%) 85 (39%) <0.001 
Question  Yes   
 Do you think it is important to perform HIV drug resistance testing when 
managing an HIV patient who is responding to ART? 
4 % <0.001 
 
Perception  
The responses to the perception section of the questionnaire are shown in table 4.   
 
 
Table 4: Perception of respondents about HIVDR testing 
 
Question 
Yes  % 
Do you think HIV drug resistance testing should be done in all hospitals 
in South Africa? 
199* 92 
Would you support the use of computer based interpretation algorithms 
when testing for HIV drug resistance here in South Africa? 
164* 76 
From your experience, do you think doctors in South Africa managing 
HIV patients are performing HIV drug resistance testing as recommended 
by international HIV clinical guidelines? 
37* 17 
Do you intend to practice the use of HIV drug resistance testing using 
computer based interpretation algorithms when managing HIV positive 
patients in the future? 
138* 64 
Do you agree to this statement, ‘Resistance testing has been advanced as 
a valuable tool in the management of HIV infected individuals?’ 
192* 89 
*P value <0.001 





Knowledge on HIV drug resistance  
 
A significant proportion of students 90% (p < 0.001) were aware of HIV drug resistance 
testing in South Africa. The same respondents confirmed they had learnt about HIV 
drug resistance testing in their studies at the university. HIVDR is part of the 
undergraduate curriculum at UKZN medical school and coupled with the burden of 
HIV in South Africa, it is of concern that 10% of the students were not aware of 
HIVDR. More emphasis is required to ensure that students understand the issue of 
HIVDR testing, and the risks of treatment failure. This is important in the context of 
limited treatment options, common in the developing countries like South Africa 
(Parkin et al., 2012).   
 
Eighty percent of the respondents confirmed having covered topics on the importance 
of HIV drug resistance 80% (p < 0.001). 80% (p < 0.001) confirmed having covered 
topics on relevancy of HIVDR in HIV management. 84% (p < 0.001) confirmed that it 
is very important to test for HIVDR when managing an HIV patient. However these 
results indicated that approximately 20% of the subset of students do not fully 
understand what is being taught on HIVDR in the curriculum. 
 
Of the 90% who confirmed having learnt about HIV drug resistance testing, only 4% 
(p <0.001) indicated that they had learnt about computer generated genotyping 
interpretation algorithms in their studies. The curriculum does not encompass computer 
based genotyping interpretation algorithms which are however highly recommended 
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for use in countries like South Africa (Parkin et al., 2012). This topic is covered during 
the clinical training component of the degree. It is important that computer generated 
genotyping interpretation algorithms are made part of the South African undergraduate 
medical school curriculum as these are important in the HIVDR testing.  The 
undergraduate medical students should be educated and exposed to the concept of these 
algorithms so that they are familiar with their existence, importance and significance in 
managing HIV patients.  
 
While 95% of the respondents had seen senior clinicians order phenotypic testing 
during their practical exposure in hospitals with HIV patients, only 5% had seen the 
senior clinician ordering HIVDR tests with computer based interpretation algorithms. 
This demonstrates lack of use, exposure to and knowledge of NRMSM medical students 
about computer based interpretation algorithms. They are familiar with the 
sophisticated laboratory testing which is not affordable for routine monitoring of HIV 
drug resistance testing in South Africa considering the burden of the disease.  
 
Clinicians need to become knowledgeable regarding the use of resistance patterns 
associated with specific antiretroviral resistance so that they may appropriately select 
treatment regimens, which will maximise the likelihood of viral suppression and this is 
only be possible if they have knowledge on how to perform these HIVDR tests. HIVDR 
testing is of vital importance in managing HIV positive patients, yet knowledge to low-
cost technologies and procedures suited to the resource limited context is still lacking 
even though regular viral load monitoring and resistance testing in the case of 
virological failure are recommended.  
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Majority of the students, 94% believed that very little HIVDR testing is currently being 
done in South Africa yet HIV drug resistance testing has been made part of HIV 
management. This continues to support the opinion that medical students need to be 
made aware of and knowledgeable on HIVDR technological testing methods 
recommended such that more HIVDR testing will be done when managing HIV 
patients. This will have a direct positive influence on the management of patients with 
HIV. 
 
Knowledge on computer interpretation algorithms 
 
While 79% (p < 0.001) of the respondents perceive the issue of HIVDR testing as 
important, it is worrying that 21% of these students feel that HIVDR testing is 
unimportant. This could be because of the students’ lack of exposure or encounter with 
HIVDR testing and the testing methods, and the failure of the curriculum to emphasise 
its importance. Table 4 question 2 shows that 18% (p < 0.001) of these respondents see 
HIVDR testing with the use of computer interpretation algorithms as unimportant even 
when virological failure has occurred.  
 
Lack of knowledge of existence of HIVDR testing with computer interpretation 
algorithms by these NRMSM undergraduate medical students continues to affect their 
decisions. Computer interpretation algorithms provide essential information for guiding 
treatment in HIV infected patients and it may be used for identifying patients with 
transmitted drug resistance or to clarify reasons for treatment failure and to check 
remaining treatment options. These computer based interpretation algorithms are being 
highly recommended for use in the resource limited countries.  





The majority of the students (78%) support that HIVDR should be done in all hospitals 
in South Africa; this could have been influenced by the attained knowledge on HIVDR 
testing even though they are not well knowledgeable on HIVDR testing methods. 
Although 96% did not know about computer based interpretation algorithms, 76% 
recommend HIVDR testing with the use of computer interpretation algorithms after 
reading a statement about what it is.  The respondents knowledge and awareness of the 
use of information communication technology (ICT) in clinical practices could have 
influenced their recommending the use of computer based interpretation algorithms in 
HIVDR testing even though they had limited or no knowledge on such imparted during  
the theoretical component of their studies.  
 
Most of the respondents, 94%, support the use of ICT in clinical practices, and 89%  
were aware of computer based clinical decision support systems (CDSS)  in clinical 
practice, and 84% will use CDSS in the future in their practice. Therefore thus seems 
to be general enthusiasm in using technology in clinical practice, however they need to 
be devoted and made aware of the possibilities, hence education is required. 
 
 83% (p < 0.001) of the respondents felt that the current doctors managing HIV patients 
were not performing HIVDR testing as recommended by HIV clinical guidelines which 
now recommends that resistance testing be made part of the HIV patient management. 
This may be due to the lack of knowledge and awareness associated with HIVDR 
testing.  It may also be due to lack of knowledge and awareness of HIVDR testing with 
computer based genotyping interpretation algorithms. Further studies should be 
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undertaken on why doctors do not perform HIVDR testing as stated in the clinical 
guidelines for HIV, HIV with invasive HIVDR continues to complicate the global 
spread of HIV disease.  
Perception 
 
89% (p < 0.001) of the respondents agreed to the statement that, ‘resistance testing has 
been advanced as a valuable tool in the management of HIV infected individuals’.  This 
continues to display the importance of knowledge in affecting one’s attitude and 
perception. A significant number of the respondents had a good understanding of the 
existence of HIVDR in the country. The current results may provide valuable reference 
data for national interventions to emphasize on the importance of drug resistance testing 
in South Africa and reduce the incidence of drug resistance in HIV patients, and thus 
improve the country's health.  
 
Collectively these observations in this study underscore the need to introduce topics on 
HIVDR testing with the use of computer genotyping interpretation algorithms in the 
curriculum and exposes students to the practical use of these algorithms.  It is important 
to expose undergraduate medical students to HIVDR testing with the recommended 
computer genotyping interpretation algorithms in order to protect the efficacy of first 
and second line regiments in HIV management. The accumulation of acquired HIVDR 
mutations underscores the need to reinforce HIVDR prevention strategies, such as 
increasing HIVDR testing and the availability and appropriate use of vilologic testing 
to monitor ART response. The scale up of HIVDR testing measurers is already treated 
as an international priority. 
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70% of the respondents that think it is important to test for HIVDR when managing an 
HIV patient, intend to practice HIVDR testing using computer based interpretation 
algorithms in the future. The limited knowledge and, exposure to the importance of 
HIVDR testing when managing an HIV patient using computer based interpretation 
algorithms affects their perception and recommendation of their use in the future. This 
shows that these medical students have knowledge on the importance of HIVDR testing 
but they have limited knowledge on HIVDR testing using computer based 
interpretation algorithms. However, with more knowledge and exposure on computer 
algorithms, their perception will be different. They are willing to use them in the future, 
which shows the need for their curriculum to educate them on these computer based 
interpretation algorithms.      
 
Lack of knowledge and exposure affects attitude and perception of a person.  There is 
need in enhancing knowledge level of a people in certain subjects of their concern such 
that attitude and perception remain positive. Since HIVDR testing is a priority when 
managing HIV patients, there is need in enhancing knowledge of the medical students 
on HIVDR testing with the recommended genotypic interpretation algorithms.  
 
From these results, it can be concluded that knowledge and exposure on HIVDR testing 
using computer based interpretation  is of vital importance to the medical students who 
intend to use these in the future of their career. It is of paramount importance that much 
is done in encompassing both theoretical and practical lessons on computer based 
interpretation algorithms. 
 





Monitoring treatment efficacy and HIV drug resistance testing are therefore of 
increasing importance in resource-limited settings. Yet low-cost technologies and 
procedures suited to the particular context and constraints of such settings are still 
lacking. The results of this paper showed that medical students have knowledge on drug 
resistance existence in South Africa but had little knowledge or exposure on drug 
resistance testing with genotyping computer interpretation algorithms. However the 
study demonstrated the willingness to learn and use artificial intelligence computer 
algorithms by the respondents.  
 
Genotyping computer interpretation algorithms are being recommended to be essential 
in managing HIV drug resistance in the developing countries. It is recommended that 
the use of HIV computer interpretation algorithms be included in the curriculum of 
medical students. The World Health Organization (WHO) has developed a global 
laboratory network to support human immunodeficiency virus drug resistance 
genotyping for public health surveillance in resource-limited countries (Parkin et al., 




Aitken, SC., Kliphuis, A., Wallis, CL., Chu, ML., Fillekes, Q., Barth, R., . . . 
Schuurman, R. (2012). Development and evaluation of an assay for HIV-1 protease 
and reverse transcriptase drug resistance genotyping of all major group-M subtypes. 
Journal of Clinical Virology, 54(1), 21-25.  




Badran, IG. (1995). Knowledge, attitude and practice: the three pillars of excellence 
and wisdom, a place in the medical profession. Relation, 1(1), 8-16.  
 
Eberle, J., & Gürtler, L. (2012). The Evolution of Drug Resistance Interpretation 
Algorithms: ANRS, REGA and Extension of Resistance Analysis to HIV-1 Group O 
and HIV-2. Intervirology, 55(2), 128-133.  
 
Kozal, MJ. (2009). Drug‐resistant human immunodefiency virus. Clinical 
Microbiology and Infection, 15(s1), 69-73.  
 
Manasa, J., Lessells, R. J., Skingsley, A., Naidu, K. K., Newell, M., McGrath, N., & 
de Oliveira, T. (2013). High-Levels of Acquired Drug Resistance in Adult Patients 
Failing First-Line Antiretroviral Therapy in a Rural HIV Treatment Programme in 
KwaZulu-Natal, South Africa. PLoS ONE, 8(8), 1-10. doi: 
10.1371/journal.pone.0072152 
 
Nwobegahay, JM., Bessong, PO., Masebe, TM., Mavhandu, LG., Iweriebor, BC., & 
Selabe, G. (2011). Prevalence of antiretroviral drug resistance mutations and HIV-I 
subtypes among newly-diagnosed drug-naïve persons visiting a voluntary testing and 
counselling centre in northeastern South Africa. Journal Of Health, Population, And 
Nutrition, 29(4), 303-309.  
 
   
43 
 
Parkin, N., Bremer, J., & Bertagnolio, S. (2012). Genotyping external quality 
assurance in the World Health Organization HIV drug resistance laboratory network 
during 2007–2010. Clinical Infectious Diseases, 54(suppl 4), S266-S272.  
 
Rusine, J., Asiimwe-Kateera, B., van de Wijgert, J., Boer, KR., Mukantwali, E., 
Karita, E., . . . Ondoa, P. (2013). Low Primary and Secondary HIV Drug-Resistance 
after 12 Months of Antiretroviral Therapy in Human Immune-Deficiency Virus Type 
1 (HIV-1)-Infected Individuals from Kigali, Rwanda. PloS One, 8(8), e64345.  
 
Singh, Y., & Mars, M. (2013). Design of an HIV drug resistant patient management 
system in a digitally connected world. Scientific Research and Essays, 8(23), 1089-
1095.  
 
Struck, D., Wallis, CL., Denisov, G., Lambert, C., Servais, J., Viana, RV., . . . 
Schuurman, R. (2012). Automated sequence analysis and editing software for HIV 
drug resistance testing. Journal of Clinical Virology, 54(1), 30-35.  
 
WHO. (2012). WHO HIV Drug Resistance Report 2012. Retrieved from World 
Health Organisation website: 
http://www.who.int/hiv/pub/drugresistance/report2012/en/ 
 
   
44 
 
CHAPTER 4: CONCLUSION 
 
Reviewed literature has described the significance of HIVDR and HIVDR testing in 
managing HIV. No literature was found relating to KAP of medical students in South 
Africa and other African countries regarding HIVDR testing with the use of computer 
interpretation algorithms. Much literature supports the use of computer interpretation 
algorithms in managing HIVDR. HIVDR testing has been shown to improve 
antiretroviral treatment outcomes and is broadly recommended as standard of care in 
current treatment guidelines, particularly for patients with prior treatment experience 
(Guertler et al., 2012). The study has shown that the majority of the sampled medical 
students at UKZN were aware if HIV resistance but had no knowledge on the use of 
computer interpretation algorithms, currently recommended for HIVDR testing.  
 
The KAP study was to assess the current level of knowledge amongst the fourth and 
fifth year medical students, their attitude and perception in performing HIVDR testing 
with the use of computer interpretation algorithms. The general perception of the 
participants was that they would use information communication technology in making 
clinical decisions in future practice even though they lacked knowledge on computer 
interpretation algorithms.  
 
The World Health Organization (WHO) global strategy for prevention and assessment 
of HIVDR consists of a coordinated plan for HIVDR surveillance in countries where 
ART has been scaled up, to guide population based selection of ART regimens (Parkin 
et al., 2012). Medical students need to be exposed to HIVDR testing using computer 
interpretation algorithms. Understanding the KAP of a community can be the only 
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strategy to the success of introducing a new program suitably. The study recommends 
the inclusion and emphasis on HIVDR testing topics in the medical students’ 
curriculum. The medical students should be equipped with all the knowledge regarding 
the HIVDR testing with the use of affordable computer technologies such that they will 
be able to request and interpret routine virological results when managing an HIV.  
 
There is need to compare KAP of medical students at other medical schools in South 
Africa or even across Africa so as to have a comprehensive cross-sectional detailed 
understanding of the use of HIVDR interpretation algorithms. Comparisons of the 
syllabus n different universities can also be one, in order to achieve the goal of 
eradicating HIVDR. Gaps can be identified and rectified regarding knowledge of 
HIVDR testing. The main finding of this study was that the medical school students 
lacked any knowledge of computer based interpretation algorithms. A limitation was 
that the research was restricted to fourth and fifth year medical students, and could have 
benefitted from the inclusion of academic staff to give a broad explanation on why 
students are not aware of HIVDR testing with the interpretation algorithms.  
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